TreeWAS – Variant ID: rs2581305

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R00.1 Bradycardia, unspecified	0.063	0.937	0.000
R91 Abnormal findings on diagnostic imaging of lung	0.000	0.982	0.018
C34.9 Bronchus or lung, unspecified	0.000	0.986	0.014
C34.1 Upper lobe, bronchus or lung	0.000	0.988	0.012
C34 Malignant neoplasm of bronchus and lung	0.000	0.989	0.011
C34.0 Main bronchus	0.000	0.991	0.009
N83.1 Corpus luteum cyst	0.009	0.991	0.000
C34.8 Overlapping lesion of bronchus and lung	0.000	0.992	0.008
R56.8 Other and unspecified convulsions	0.008	0.992	0.000
C34.2 Middle lobe, bronchus or lung	0.000	0.992	0.008
R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract	0.000	0.992	0.008
R90-R94 Abnormal findings on diagnostic imaging and in function studies, without diagnosis	0.000	0.993	0.007
R93 Abnormal findings on diagnostic imaging of other body structures	0.000	0.993	0.007
C34.3 Lower lobe, bronchus or lung	0.000	0.993	0.007
R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation	0.000	0.994	0.006
K13.7 Other and unspecified lesions of oral mucosa	0.006	0.994	0.000
R93.5 Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum	0.000	0.994	0.006
R30.0 Dysuria	0.000	0.995	0.005
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract	0.000	0.995	0.005
R92 Abnormal findings on diagnostic imaging of breast	0.000	0.995	0.005
R93.6 Abnormal findings on diagnostic imaging of limbs	0.000	0.995	0.005
R79.8 Other specified abnormal findings of blood chemistry	0.000	0.995	0.005
R93.7 Abnormal findings on diagnostic imaging of other parts of musculoskeletal system	0.000	0.995	0.005
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)	0.000	0.995	0.005
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.995	0.005
R93.4 Abnormal findings on diagnostic imaging of urinary organs	0.000	0.995	0.004
R90 Abnormal findings on diagnostic imaging of central nervous system	0.000	0.996	0.004
I31.3 Pericardial effusion (noninflammatory)	0.004	0.996	0.000
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.000	0.996	0.004
R94 Abnormal results of function studies	0.000	0.996	0.004
R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified	0.000	0.996	0.004
R79 Other abnormal findings of blood chemistry	0.000	0.996	0.004
M20.5 Other deformities of toe(s) (acquired)	0.004	0.996	0.000
R93.8 Abnormal findings on diagnostic imaging of other specified body structures	0.000	0.996	0.004
R94.8 Abnormal results of function studies of other organs and systems	0.000	0.996	0.004
R56 Convulsions, not elsewhere classified	0.004	0.996	0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.000	0.996	0.004
R79.9 Abnormal finding of blood chemistry, unspecified	0.000	0.996	0.004
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.996	0.004
J34.2 Deviated nasal septum	0.004	0.996	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.003
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
R94.1 Abnormal results of function studies of peripheral nervous system and special senses	0.000	0.997	0.003
R79.0 Abnormal level of blood mineral	0.000	0.997	0.003
R94.6 Abnormal results of thyroid function studies	0.000	0.997	0.003
T40.6 Other and unspecified narcotics	0.000	0.997	0.003
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.997	0.003
R90.0 Intracranial space-occupying lesion	0.000	0.997	0.003
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.003
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.997	0.003
I12.0 Hypertensive renal disease with renal failure	0.000	0.997	0.003
R94.7 Abnormal results of other endocrine function studies	0.000	0.997	0.003
R56.0 Febrile convulsions	0.003	0.997	0.000
R94.0 Abnormal results of function studies of central nervous system	0.000	0.997	0.003
R94.2 Abnormal results of pulmonary function studies	0.000	0.997	0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
I31 Other diseases of pericardium	0.003	0.997	0.000
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.003	0.997	0.000
R00 Abnormalities of heart beat	0.003	0.997	0.000
M65.9 Synovitis and tenosynovitis, unspecified	0.000	0.997	0.003
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
T44.0 Anticholinesterase agents	0.000	0.997	0.003
T40.5 Cocaine	0.000	0.997	0.003
I31.9 Disease of pericardium, unspecified	0.003	0.997	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
R94.5 Abnormal results of liver function studies	0.000	0.997	0.003
T43.9 Psychotropic drug, unspecified	0.000	0.997	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.997	0.003
K13 Other diseases of lip and oral mucosa	0.003	0.997	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.000	0.997	0.003
T40.2 Other opioids	0.000	0.997	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
I44.1 Atrioventricular block, second degree	0.003	0.997	0.000
T40.4 Other synthetic narcotics	0.000	0.997	0.003
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
T40.1 Heroin	0.000	0.997	0.003
G50.0 Trigeminal neuralgia	0.000	0.997	0.003
H54.4 Blindness, one eye	0.003	0.997	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.997	0.003
K13.4 Granuloma and granuloma-like lesions of oral mucosa	0.003	0.997	0.000
R94.3 Abnormal results of cardiovascular function studies	0.000	0.997	0.003
T40.3 Methadone	0.000	0.997	0.003
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)	0.000	0.997	0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.997	0.003
T40.8 Lysergide [LSD]	0.000	0.997	0.003
T40.7 Cannabis (derivatives)	0.000	0.997	0.003
T40.0 Opium	0.000	0.997	0.003
R90.8 Other abnormal findings on diagnostic imaging of central nervous system	0.000	0.997	0.002
T43.6 Psychostimulants with abuse potential	0.000	0.997	0.002
R94.4 Abnormal results of kidney function studies	0.000	0.997	0.002
I31.1 Chronic constrictive pericarditis	0.002	0.997	0.000
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.000	0.997	0.003
N41.0 Acute prostatitis	0.000	0.997	0.003
I31.0 Chronic adhesive pericarditis	0.002	0.998	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
I31.8 Other specified diseases of pericardium	0.002	0.998	0.000
I31.2 Haemopericardium, not elsewhere classified	0.002	0.998	0.000
K08.3 Retained dental root	0.000	0.998	0.002
H53.9 Visual disturbance, unspecified	0.002	0.998	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.000	0.998	0.002
R72 Abnormality of white blood cells, not elsewhere classified	0.000	0.998	0.002
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)	0.000	0.998	0.002
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)	0.000	0.998	0.002
R09.0 Asphyxia	0.000	0.998	0.002
T43.2 Other and unspecified antidepressants	0.000	0.998	0.002
C38 Malignant neoplasm of heart, mediastinum and pleura	0.000	0.998	0.002
H54 Blindness and low vision	0.002	0.998	0.000
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)	0.000	0.998	0.002
M65.98 Synovitis and tenosynovitis, unspecified (Other)	0.000	0.998	0.002
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
H54.0 Blindness, both eyes	0.002	0.998	0.000
J35.8 Other chronic diseases of tonsils and adenoids	0.000	0.998	0.002
N40 Hyperplasia of prostate	0.000	0.998	0.002
I42.0 Dilated cardiomyopathy	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
K13.2 Leukoplakia and other disturbances of oral epithelium, including tongue	0.002	0.998	0.000
K13.3 Hairy leukoplakia	0.002	0.998	0.000
K13.1 Cheek and lip biting	0.002	0.998	0.000
C31 Malignant neoplasm of accessory sinuses	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.000	0.998	0.002
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
J34.3 Hypertrophy of nasal turbinates	0.002	0.998	0.000
K13.5 Oral submucous fibrosis	0.002	0.998	0.000
T39.0 Salicylates	0.000	0.998	0.002
C33 Malignant neoplasm of trachea	0.000	0.998	0.002
R30 Pain associated with micturition	0.000	0.998	0.002
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)	0.000	0.998	0.002
K13.6 Irritative hyperplasia of oral mucosa	0.002	0.998	0.000
C37 Malignant neoplasm of thymus	0.000	0.998	0.002
I35.0 Aortic (valve) stenosis	0.002	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
H53.4 Visual field defects	0.002	0.998	0.000
O36.8 Maternal care for other specified foetal problems	0.000	0.998	0.002
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.998	0.002
H54.9 Unspecified visual impairment (binocular)	0.002	0.998	0.000
H47.3 Other disorders of optic disk	0.000	0.998	0.002
L08 Other local infections of skin and subcutaneous tissue	0.000	0.998	0.002
J38.3 Other diseases of vocal cords	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.998	0.002
R70-R79 Abnormal findings on examination of blood, without diagnosis	0.000	0.998	0.002
R30.1 Vesical tenesmus	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
A46 Erysipelas	0.000	0.998	0.002
R76 Other abnormal immunological findings in serum	0.000	0.998	0.002
C30.0 Nasal cavity	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T36.0 Penicillins	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
T42.3 Barbiturates	0.000	0.998	0.002
M65.94 Synovitis and tenosynovitis, unspecified (Hand)	0.000	0.998	0.002
G51.0 Bell's palsy	0.002	0.998	0.000
H54.3 Unqualified visual loss, both eyes	0.002	0.998	0.000
C38.3 Mediastinum, part unspecified	0.000	0.998	0.002
C30.1 Middle ear	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.000	0.998	0.002
C38.2 Posterior mediastinum	0.000	0.998	0.002
C38.1 Anterior mediastinum	0.000	0.998	0.002
C38.0 Heart	0.000	0.998	0.002
H25.8 Other senile cataract	0.002	0.998	0.000
H54.2 Low vision, both eyes	0.002	0.998	0.000
R76.8 Other specified abnormal immunological findings in serum	0.000	0.998	0.002
C38.4 Pleura	0.000	0.998	0.002
C39.9 Ill-defined sites within the respiratory system	0.000	0.998	0.002
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.000	0.998	0.002
C39.0 Upper respiratory tract, part unspecified	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.000	0.998	0.002
G56.2 Lesion of ulnar nerve	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
H54.7 Unspecified visual loss	0.002	0.998	0.000
H54.5 Low vision, one eye	0.002	0.998	0.000
K08.8 Other specified disorders of teeth and supporting structures	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.998	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
K13.29 Other disturbances of oral epithelium, including tongue	0.002	0.998	0.000
C31.9 Accessory sinus, unspecified	0.000	0.998	0.002
C31.8 Overlapping lesion of accessory sinuses	0.000	0.998	0.002
C31.3 Sphenoidal sinus	0.000	0.998	0.002
C31.2 Frontal sinus	0.000	0.998	0.002
C31.1 Ethmoidal sinus	0.000	0.998	0.002
H54.1 Blindness, one eye, low vision, other eye	0.002	0.998	0.000
K13.0 Diseases of lips	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T42.4 Benzodiazepines	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
E87.2 Acidosis	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.998	0.002
M79.89 Other specified soft tissue disorders (Site unspecified)	0.002	0.998	0.000
L08.8 Other specified local infections of skin and subcutaneous tissue	0.000	0.998	0.002
R00.8 Other and unspecified abnormalities of heart beat	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.998	0.002
T42.0 Hydantoin derivatives	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
H54.6 Unqualified visual loss, one eye	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
C32 Malignant neoplasm of larynx	0.000	0.998	0.002
R76.0 Raised antibody titer	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
H53 Visual disturbances	0.002	0.998	0.000
C31.0 Maxillary sinus	0.000	0.998	0.002
H83.0 Labyrinthitis	0.000	0.998	0.002
I70.2 Atherosclerosis of arteries of the extremities	0.000	0.998	0.002
R68.8 Other specified general symptoms and signs	0.000	0.998	0.002
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
K08 Other disorders of teeth and supporting structures	0.000	0.998	0.002
K08.1 Loss of teeth due to accident, extraction or local periodontal disease	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
L08.1 Erythrasma	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
R78 Findings of drugs and other substances, not normally found in blood	0.000	0.998	0.002
R75 Laboratory evidence of human immunodeficiency virus [HIV]	0.000	0.998	0.002
L08.0 Pyoderma	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.998	0.002
N41 Inflammatory diseases of prostate	0.000	0.998	0.002
M79.86 Other specified soft tissue disorders (Lower leg)	0.002	0.998	0.000
R76.2 False-positive serological test for syphilis	0.000	0.998	0.002
R76.1 Abnormal reaction to tuberculin test	0.000	0.998	0.002
J34 Other disorders of nose and nasal sinuses	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.001
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.998	0.002
N41.9 Inflammatory disease of prostate, unspecified	0.000	0.998	0.002
W18.3 Sports and athletics area	0.000	0.998	0.002
R77 Other abnormalities of plasma proteins	0.000	0.998	0.002
I33.0 Acute and subacute infective endocarditis	0.002	0.998	0.000
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.002	0.998	0.000
R76.9 Abnormal immunological finding in serum, unspecified	0.000	0.998	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.002
R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity	0.000	0.998	0.002
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.998	0.002
I42.8 Other cardiomyopathies	0.002	0.998	0.000
S06.2 Diffuse brain injury	0.000	0.998	0.002
R74 Abnormal serum enzyme levels	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.001
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.001
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.001
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.001
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.001
C82.2 Large cell, follicular	0.000	0.998	0.002
I63 Cerebral infarction	0.000	0.998	0.002
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.001
T45.4 Iron and its compounds	0.000	0.998	0.001
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.002	0.998	0.000
H47.2 Optic atrophy	0.000	0.998	0.002
H53.5 Colour vision deficiencies	0.002	0.998	0.000
T42.1 Iminostilbenes	0.000	0.998	0.001
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.001
C32.8 Overlapping lesion of larynx	0.000	0.998	0.001
C32.3 Laryngeal cartilage	0.000	0.998	0.001
C32.2 Subglottis	0.000	0.998	0.001
R74.0 Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]	0.000	0.998	0.001
T45.5 Anticoagulants	0.000	0.998	0.001
I42 Cardiomyopathy	0.002	0.998	0.000
H53-H54 Visual disturbances and blindness	0.002	0.998	0.000
M79.85 Other specified soft tissue disorders (Pelvic region and thigh)	0.002	0.998	0.000
M79.8 Other specified soft tissue disorders	0.002	0.998	0.000
N41.1 Chronic prostatitis	0.000	0.998	0.002
R78.8 Finding of other specified substances, not normally found in blood	0.000	0.998	0.001
W19.4 Street and highway	0.000	0.998	0.002
C32.1 Supraglottis	0.000	0.998	0.001
H53.6 Night blindness	0.001	0.998	0.000
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries	0.000	0.998	0.002
K08.2 Atrophy of edentulous alveolar ridge	0.000	0.998	0.001
K08.0 Exfoliation of teeth due to systemic causes	0.000	0.998	0.001
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.000	0.998	0.002
S32.00 Fracture of lumbar vertebra (closed)	0.002	0.998	0.000
R30.9 Painful micturition, unspecified	0.000	0.998	0.001
R77.9 Abnormality of plasma protein, unspecified	0.000	0.998	0.001
R78.9 Finding of unspecified substance, not normally found in blood	0.000	0.998	0.001
R78.7 Finding of abnormal level of heavy metals in blood	0.000	0.998	0.001
R78.6 Finding of steroid agent in blood	0.000	0.998	0.001
R78.5 Finding of psychotropic drug in blood	0.000	0.998	0.001
R78.4 Finding of other drugs of addictive potential in blood	0.000	0.998	0.001
R78.3 Finding of hallucinogen in blood	0.000	0.998	0.001
R78.2 Finding of cocaine in blood	0.000	0.998	0.001
R78.1 Finding of opiate drug in blood	0.000	0.998	0.001
T50.8 Diagnostic agents	0.000	0.998	0.001
C18.0 Caecum	0.002	0.998	0.000
C82.6 Cutaneous follicle centre lymphoma	0.000	0.998	0.001
C82.5 Diffuse follicle centre lymphoma	0.000	0.998	0.001
H53.3 Other disorders of binocular vision	0.001	0.998	0.000
N41.8 Other inflammatory diseases of prostate	0.000	0.998	0.001
N41.3 Prostatocystitis	0.000	0.998	0.001
R74.9 Abnormal level of unspecified serum enzyme	0.000	0.998	0.001
R77.0 Abnormality of albumin	0.000	0.998	0.001
I12 Hypertensive renal disease	0.000	0.998	0.002
I35.8 Other aortic valve disorders	0.001	0.998	0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.000	0.998	0.001
N41.2 Abscess of prostate	0.000	0.998	0.001
R77.2 Abnormality of alphafetoprotein	0.000	0.998	0.001
R77.1 Abnormality of globulin	0.000	0.998	0.001
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.001
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.001
T46.7 Peripheral vasodilators	0.000	0.998	0.001
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.001
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.001
T50.5 Appetite depressants	0.000	0.998	0.001
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.001
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.001
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.001
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.001
R78.0 Finding of alcohol in blood	0.000	0.998	0.001
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.001
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.001
R71 Abnormality of red blood cells	0.000	0.998	0.001
S06.21 Diffuse brain injury (with open intracranial wound)	0.000	0.998	0.001
C82.4 Follicular lymphoma grade IIIb	0.000	0.998	0.001
C82.3 Follicular lymphoma grade IIIa	0.000	0.998	0.001
G51.3 Clonic hemifacial spasm	0.001	0.998	0.000
I42.6 Alcoholic cardiomyopathy	0.001	0.998	0.000
H47 Other disorders of optic [2nd] nerve and visual pathways	0.000	0.998	0.001
M79.82 Other specified soft tissue disorders (Upper arm)	0.001	0.998	0.000
E66.8 Other obesity	0.002	0.998	0.000
I63.9 Cerebral infarction, unspecified	0.000	0.998	0.001
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic	0.000	0.998	0.001
R70.1 Abnormal plasma viscosity	0.000	0.998	0.001
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.001
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.001
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.001
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.001	0.998	0.001
N23 Unspecified renal colic	0.000	0.998	0.002
M79.80 Other specified soft tissue disorders (Multiple sites)	0.001	0.999	0.000
I63.1 Cerebral infarction due to embolism of precerebral arteries	0.000	0.999	0.001
T46.1 Calcium-channel blockers	0.000	0.999	0.001
S82.60 Fracture of lateral malleolus (closed)	0.001	0.999	0.000
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.001	0.999	0.000
M21.27 Flexion deformity (Ankle and foot)	0.001	0.999	0.000
I42.5 Other restrictive cardiomyopathy	0.001	0.999	0.000
I42.3 Endomyocardial (eosinophilic) disease	0.001	0.999	0.000
I42.1 Obstructive hypertrophic cardiomyopathy	0.001	0.999	0.000
K08.9 Disorder of teeth and supporting structures, unspecified	0.000	0.999	0.001
Y54.3 Benzothiadiazine derivatives	0.000	0.999	0.001
Z01.8 Other specified special examinations	0.001	0.999	0.000
M19.94 Arthrosis, unspecified (Hand)	0.001	0.999	0.000
M79.81 Other specified soft tissue disorders (Shoulder region)	0.001	0.999	0.000
C32.9 Larynx, unspecified	0.000	0.999	0.001
C82.0 Small cleaved cell, follicular	0.000	0.999	0.001
H53.1 Subjective visual disturbances	0.001	0.999	0.000
R70.0 Elevated erythrocyte sedimentation rate	0.000	0.999	0.001
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.999	0.001
M21.24 Flexion deformity (Hand)	0.001	0.999	0.000
S22.10 Multiple fractures of thoracic spine (closed)	0.000	0.999	0.001
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.001	0.999	0.000
M21.26 Flexion deformity (Lower leg)	0.001	0.999	0.000
C15.9 Oesophagus, unspecified	0.001	0.999	0.000
C32.0 Glottis	0.000	0.999	0.001
H53.8 Other visual disturbances	0.001	0.999	0.000
H53.2 Diplopia	0.001	0.999	0.000
M21.2 Flexion deformity	0.001	0.999	0.000
R77.8 Other specified abnormalities of plasma proteins	0.000	0.999	0.001
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.999	0.001
C15.5 Lower third of oesophagus	0.001	0.999	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.999	0.001
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.999	0.001
I42.7 Cardiomyopathy due to drugs and other external agents	0.001	0.999	0.000
Y54.8 Agents affecting uric acid metabolism	0.000	0.999	0.001
G51 Facial nerve disorders	0.001	0.999	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.001	0.999	0.000
S82.10 Fracture of upper end of tibia (closed)	0.001	0.999	0.000
C93.1 Chronic monocytic leukaemia	0.000	0.999	0.001
H50.1 Divergent concomitant strabismus	0.000	0.999	0.001
I42.2 Other hypertrophic cardiomyopathy	0.001	0.999	0.000
K22.2 Oesophageal obstruction	0.001	0.999	0.000
K83.1 Obstruction of bile duct	0.001	0.999	0.000
Y95 Nosocomial condition	0.000	0.999	0.001
H47.7 Disorder of visual pathways, unspecified	0.000	0.999	0.001
H47.6 Disorders of visual cortex	0.000	0.999	0.001
H47.5 Disorders of other visual pathways	0.000	0.999	0.001
H47.4 Disorders of optic chiasm	0.000	0.999	0.001
I42.4 Endocardial fibroelastosis	0.001	0.999	0.000
J34.0 Abscess, furuncle and carbuncle of nose	0.001	0.999	0.000
E27 Other disorders of adrenal gland	0.000	0.999	0.001
I33 Acute and subacute endocarditis	0.001	0.999	0.000
M79.88 Other specified soft tissue disorders (Other)	0.001	0.999	0.000
M79.83 Other specified soft tissue disorders (Forearm)	0.001	0.999	0.000
E27.9 Disorder of adrenal gland, unspecified	0.000	0.999	0.001
I63.0 Cerebral infarction due to thrombosis of precerebral arteries	0.000	0.999	0.001
M21.22 Flexion deformity (Upper arm)	0.001	0.999	0.000
E27.2 Addisonian crisis	0.000	0.999	0.001
E27.1 Primary adrenocortical insufficiency	0.000	0.999	0.001
H47.0 Disorders of optic nerve, not elsewhere classified	0.000	0.999	0.001
I33.9 Acute endocarditis, unspecified	0.001	0.999	0.000
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.000	0.999	0.001
N83.6 Haematosalpinx	0.001	0.999	0.000
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.001	0.999	0.000
M21.25 Flexion deformity (Pelvic region and thigh)	0.001	0.999	0.000
M21.23 Flexion deformity (Forearm)	0.001	0.999	0.000
M21.20 Flexion deformity (Multiple sites)	0.001	0.999	0.000
G51.9 Disorder of facial nerve, unspecified	0.001	0.999	0.000
M21.29 Flexion deformity (Site unspecified)	0.001	0.999	0.000
M21.28 Flexion deformity (Other)	0.001	0.999	0.000
M21.21 Flexion deformity (Shoulder region)	0.001	0.999	0.000
I63.8 Other cerebral infarction	0.000	0.999	0.001
J38.1 Polyp of vocal cord and larynx	0.001	0.999	0.000
N83.7 Haematoma of broad ligament	0.001	0.999	0.000
T14.0 Superficial injury of unspecified body region	0.001	0.999	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.001	0.999	0.001
Y54.5 Other diuretics	0.000	0.999	0.001
H47.1 Papilloedema, unspecified	0.000	0.999	0.001
I12.9 Hypertensive renal disease without renal failure	0.000	0.999	0.001
I42.9 Cardiomyopathy, unspecified	0.001	0.999	0.000
J34.1 Cyst and mucocele of nose and nasal sinus	0.001	0.999	0.000
N42.9 Disorder of prostate, unspecified	0.000	0.999	0.001
S82.00 Fracture of patella (closed)	0.001	0.999	0.000
G51.4 Facial myokymia	0.001	0.999	0.000
G51.2 Melkersson's syndrome	0.001	0.999	0.000
G51.1 Geniculate ganglionitis	0.001	0.999	0.000
H65.3 Chronic mucoid otitis media	0.001	0.999	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.000	0.999	0.001
Z80.4 Family history of malignant neoplasm of genital organs	0.000	0.999	0.001
I35 Nonrheumatic aortic valve disorders	0.001	0.999	0.000
I38 Endocarditis, valve unspecified	0.001	0.999	0.000
R73 Elevated blood glucose level	0.000	0.999	0.001
W18 Other fall on same level	0.000	0.999	0.001
C15.3 Upper third of oesophagus	0.001	0.999	0.000
C95.9 Leukaemia, unspecified	0.000	0.999	0.001
E27.5 Adrenomedullary hyperfunction	0.000	0.999	0.001
E27.0 Other adrenocortical overactivity	0.000	0.999	0.001
G51.8 Other disorders of facial nerve	0.001	0.999	0.000
T39.1 4-Aminophenol derivatives	0.000	0.999	0.001
W10.8 Other specified place	0.000	0.999	0.001
C15 Malignant neoplasm of oesophagus	0.001	0.999	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.000	0.999	0.001
A49.9 Bacterial infection, unspecified	0.000	0.999	0.001
I45.1 Other and unspecified right bundle-branch block	0.001	0.999	0.000
R25.2 Cramp and spasm	0.001	0.999	0.000
Z50.0 Cardiac rehabilitation	0.001	0.999	0.000
E27.8 Other specified disorders of adrenal gland	0.000	0.999	0.001
S79.9 Unspecified injury of hip and thigh	0.000	0.999	0.001
W14.9 Unspecified place	0.000	0.999	0.001
C93 Monocytic leukaemia	0.000	0.999	0.001
C15.1 Thoracic part of oesophagus	0.001	0.999	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.999	0.001
H34.8 Other retinal vascular occlusions	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations